Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning.

Source:http://linkedlifedata.com/resource/pubmed/id/21135860

Download in:

View as

General Info

PMID
21135860